Effectiveness of a Risk Screener in Identifying Hepatitis C Virus in a Primary Care Setting
Bibliographic Data
Objectives. We evaluated an intervention designed to identify patients at risk for hepatitis C virus (HCV) through a risk screener used by primary care providers. Methods. A clinical reminder sticker prompted physicians at 3 urban clinics to screen patients for 12 risk factors and order HCV testing if any risks were present. Risk factor data were collected from the sticker; demographic and testing data were extracted from electronic medical records. We used the t test, χ 2 test, and rank-sum test to compare patients who had and had not been screened and developed an analytic model to identify the incremental value of each element of the screener. Results. Among screened patients, 27.8% (n = 902) were identified as having at least 1 risk factor. Of screened patients with risk factors, 55.4% (n = 500) were tested for HCV. Our analysis showed that 7 elements (injection drug use, intranasal drug use, elevated alanine aminotransferase, transfusions before 1992, ≥ 20 lifetime sex partners, maternal HCV, existing liver disease) accounted for all HCV infections identified. Conclusions. A brief risk screener with a paper-based clinical reminder was effective in increasing HCV testing in a primary care setting
Family medicine · Hepatitis C · Hepatitis C virus · Medical record · Primary care · Risk factor · Virus · Diabetes Management and Education · Health Literacy and Information Accessibility · Hepatitis C virus research · Immunology · Internal Medicine · Medicine
Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Previous Exposure to HCV Among Persons Born During 1945–1965
| Unique citing works | 8 |
|---|---|
| Citations per year | 0,67 |
| Citation span | 2014 - 2023 (10) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 8 |